<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="jog14384-tbl-0001" xml:lang="en" content-type="Table" orientation="portrait" position="float">
 <label>Table 1</label>
 <caption>
  <p>Possible therapeutics for COVID‐19 during Pregnancy</p>
 </caption>
 <table frame="hsides" rules="groups">
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <thead valign="top">
   <tr style="border-bottom:solid 1px #000000">
    <th align="left" valign="top" rowspan="1" colspan="1"/>
    <th align="left" valign="top" rowspan="1" colspan="1">Description</th>
    <th align="left" valign="top" rowspan="1" colspan="1">Licensed for</th>
    <th align="left" valign="top" rowspan="1" colspan="1">Administration</th>
    <th align="left" valign="top" rowspan="1" colspan="1">Status of Use in Japan</th>
    <th align="left" valign="top" rowspan="1" colspan="1">Indication for pregnant patients</th>
   </tr>
  </thead>
  <tbody valign="top">
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Corticosteroids</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Analogues of steroid hormones</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Bronchial asthma etc.</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Inhalted</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Ongoing clinical trial</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Yes</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Hydroxy chloroquine</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Malaria, Systemic lupus erythematosus</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Malaria, SLE etc.</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Oral or intravenous</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Ongoing clinical trial</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Yes</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Ritonavir+Lopinavir(Kaletra)</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Protease inhibitors</td>
    <td align="left" valign="top" rowspan="1" colspan="1">HIV/AIDS</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Oral</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Ongoing clinical trial</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Yes</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Favipiravir (Avigan)</td>
    <td align="left" valign="top" rowspan="1" colspan="1">RNA polymerase inhibitor</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Influenza</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Oral</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Ongoing clinical trial</td>
    <td align="left" valign="top" rowspan="1" colspan="1">
     <p>No</p>
     <p>(teratogenous)</p>
    </td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Convalescent plasma</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Polyclonal human antibodies</td>
    <td align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Intravenous</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Not obtainable in Japan</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Yes</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Remdesivir</td>
    <td align="left" valign="top" rowspan="1" colspan="1">RNA polymerase inhibitor</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Various RNA virus infections</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Intravenous</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Covered by National Health Insurance</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Yes</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Tocilizumab</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Anti IL‐6 monoclonal Ab</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Rheumatoid arthritis</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Intravenous</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Ongoing clinical trial</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Yes</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
